View Financial HealthLibra Infusions 배당 및 자사주 매입배당 기준 점검 0/6Libra Infusions 은(는) 현재 수익률이 0.15% 인 배당금 지급 회사입니다.핵심 정보0.2%배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트Upcoming Dividend • Nov 06Upcoming dividend of ৳3.00 per share at 0.2% yieldEligible shareholders must have bought the stock before 13 November 2023. Payment date: 01 January 2024. Trailing yield: 0.2%. Lower than top quartile of Bangladeshi dividend payers (3.2%). Lower than average of industry peers (2.5%).Upcoming Dividend • Aug 07Upcoming dividend of ৳0.50 per shareEligible shareholders must have bought the stock before 14 August 2022. Payment date: 20 September 2022. Trailing yield: 0.1%. Lower than top quartile of Bangladeshi dividend payers (3.7%). Lower than average of industry peers (1.9%).공시 • Jul 25Libra Infusions Limited Recommends Cash DividendThe Board of Directors of Libra Infusions Limited has recommended 5% cash dividend only for General Shareholders other than Sponsors and Directors for the year ended June 30, 2020.Upcoming Dividend • Apr 27Upcoming dividend of ৳0.50 per shareEligible shareholders must have bought the stock before 04 May 2021. Payment date: 23 June 2021. Trailing yield: 0.4%. Lower than top quartile of Bangladeshi dividend payers (3.5%). Lower than average of industry peers (1.5%).모든 업데이트 보기Recent updatesBoard Change • May 20Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. 2 independent directors (6 non-independent directors). Independent Director Enamul Kabir was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.New Risk • Sep 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Bangladeshi stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported June 2019 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Market cap is less than US$100m (৳1.97b market cap, or US$16.4m).Board Change • Apr 26Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 6 non-independent directors. Independent Director Enamul Kabir was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Upcoming Dividend • Nov 06Upcoming dividend of ৳3.00 per share at 0.2% yieldEligible shareholders must have bought the stock before 13 November 2023. Payment date: 01 January 2024. Trailing yield: 0.2%. Lower than top quartile of Bangladeshi dividend payers (3.2%). Lower than average of industry peers (2.5%).New Risk • Oct 28New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Bangladeshi stocks, typically moving 7.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported June 2019 fiscal period end). Share price has been highly volatile over the past 3 months (7.9% average weekly change). Minor Risk Market cap is less than US$100m (৳2.54b market cap, or US$23.0m).공시 • Oct 24Libra Infusions Limited, Annual General Meeting, Nov 30, 2023Libra Infusions Limited, Annual General Meeting, Nov 30, 2023, at 11:00 Bangladesh Standard Time.Board Change • Nov 21Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 6 non-independent directors. Independent Director Enamul Kabir was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Upcoming Dividend • Aug 07Upcoming dividend of ৳0.50 per shareEligible shareholders must have bought the stock before 14 August 2022. Payment date: 20 September 2022. Trailing yield: 0.1%. Lower than top quartile of Bangladeshi dividend payers (3.7%). Lower than average of industry peers (1.9%).공시 • Jul 25Libra Infusions Limited Recommends Cash DividendThe Board of Directors of Libra Infusions Limited has recommended 5% cash dividend only for General Shareholders other than Sponsors and Directors for the year ended June 30, 2020.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. 2 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Upcoming Dividend • Apr 27Upcoming dividend of ৳0.50 per shareEligible shareholders must have bought the stock before 04 May 2021. Payment date: 23 June 2021. Trailing yield: 0.4%. Lower than top quartile of Bangladeshi dividend payers (3.5%). Lower than average of industry peers (1.5%).Is New 90 Day High Low • Mar 01New 90-day high: ৳685The company is up 17% from its price of ৳586 on 01 December 2020. The Bangladeshi market is up 15% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Pharmaceuticals industry, which is also up 17% over the same period.Is New 90 Day High Low • Feb 01New 90-day low: ৳582The company is down 11% from its price of ৳657 on 03 November 2020. The Bangladeshi market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 21% over the same period.Is New 90 Day High Low • Dec 21New 90-day high: ৳677The company is up 1.0% from its price of ৳670 on 22 September 2020. The Bangladeshi market is also up 1.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Pharmaceuticals industry, which is up 5.0% over the same period.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: LIBRAINFU BD 시장에서 주목할만한 배당금을 지급하지 않으므로 지급이 안정적인지 확인할 필요가 없습니다.배당금 증가: LIBRAINFU BD 시장에서 주목할만한 배당금을 지급하지 않으므로 지급액이 증가하는지 확인할 필요가 없습니다.배당 수익률 vs 시장Libra Infusions 배당 수익률 vs 시장LIBRAINFU의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (LIBRAINFU)0.2%시장 하위 25% (BD)0.8%시장 상위 25% (BD)3.5%업계 평균 (Pharmaceuticals)3.6%분석가 예측 (LIBRAINFU) (최대 3년)n/a주목할만한 배당금: LIBRAINFU 의 배당금( 0.15% )은 BD 시장에서 배당금 지급자의 하위 25%( 0.75% )와 비교해 주목할 만하지 않습니다.고배당: LIBRAINFU 의 배당금( 0.15% )은 BD 시장에서 배당금 지급자의 상위 25%( 3.47% )와 비교해 낮습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 LIBRAINFU 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: 배당금 지급이 현금 흐름에 의해 충당되는지 판단하기 위해 LIBRAINFU 의 현금 지급 비율을 계산하기에는 데이터가 부족합니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YBD 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/30 18:56종가2026/06/30 00:00수익2019/06/30연간 수익2019/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Libra Infusions Limited는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Upcoming Dividend • Nov 06Upcoming dividend of ৳3.00 per share at 0.2% yieldEligible shareholders must have bought the stock before 13 November 2023. Payment date: 01 January 2024. Trailing yield: 0.2%. Lower than top quartile of Bangladeshi dividend payers (3.2%). Lower than average of industry peers (2.5%).
Upcoming Dividend • Aug 07Upcoming dividend of ৳0.50 per shareEligible shareholders must have bought the stock before 14 August 2022. Payment date: 20 September 2022. Trailing yield: 0.1%. Lower than top quartile of Bangladeshi dividend payers (3.7%). Lower than average of industry peers (1.9%).
공시 • Jul 25Libra Infusions Limited Recommends Cash DividendThe Board of Directors of Libra Infusions Limited has recommended 5% cash dividend only for General Shareholders other than Sponsors and Directors for the year ended June 30, 2020.
Upcoming Dividend • Apr 27Upcoming dividend of ৳0.50 per shareEligible shareholders must have bought the stock before 04 May 2021. Payment date: 23 June 2021. Trailing yield: 0.4%. Lower than top quartile of Bangladeshi dividend payers (3.5%). Lower than average of industry peers (1.5%).
Board Change • May 20Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. 2 independent directors (6 non-independent directors). Independent Director Enamul Kabir was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
New Risk • Sep 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Bangladeshi stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported June 2019 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Market cap is less than US$100m (৳1.97b market cap, or US$16.4m).
Board Change • Apr 26Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 6 non-independent directors. Independent Director Enamul Kabir was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Upcoming Dividend • Nov 06Upcoming dividend of ৳3.00 per share at 0.2% yieldEligible shareholders must have bought the stock before 13 November 2023. Payment date: 01 January 2024. Trailing yield: 0.2%. Lower than top quartile of Bangladeshi dividend payers (3.2%). Lower than average of industry peers (2.5%).
New Risk • Oct 28New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Bangladeshi stocks, typically moving 7.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported June 2019 fiscal period end). Share price has been highly volatile over the past 3 months (7.9% average weekly change). Minor Risk Market cap is less than US$100m (৳2.54b market cap, or US$23.0m).
공시 • Oct 24Libra Infusions Limited, Annual General Meeting, Nov 30, 2023Libra Infusions Limited, Annual General Meeting, Nov 30, 2023, at 11:00 Bangladesh Standard Time.
Board Change • Nov 21Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 6 non-independent directors. Independent Director Enamul Kabir was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Upcoming Dividend • Aug 07Upcoming dividend of ৳0.50 per shareEligible shareholders must have bought the stock before 14 August 2022. Payment date: 20 September 2022. Trailing yield: 0.1%. Lower than top quartile of Bangladeshi dividend payers (3.7%). Lower than average of industry peers (1.9%).
공시 • Jul 25Libra Infusions Limited Recommends Cash DividendThe Board of Directors of Libra Infusions Limited has recommended 5% cash dividend only for General Shareholders other than Sponsors and Directors for the year ended June 30, 2020.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. 2 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Upcoming Dividend • Apr 27Upcoming dividend of ৳0.50 per shareEligible shareholders must have bought the stock before 04 May 2021. Payment date: 23 June 2021. Trailing yield: 0.4%. Lower than top quartile of Bangladeshi dividend payers (3.5%). Lower than average of industry peers (1.5%).
Is New 90 Day High Low • Mar 01New 90-day high: ৳685The company is up 17% from its price of ৳586 on 01 December 2020. The Bangladeshi market is up 15% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Pharmaceuticals industry, which is also up 17% over the same period.
Is New 90 Day High Low • Feb 01New 90-day low: ৳582The company is down 11% from its price of ৳657 on 03 November 2020. The Bangladeshi market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 21% over the same period.
Is New 90 Day High Low • Dec 21New 90-day high: ৳677The company is up 1.0% from its price of ৳670 on 22 September 2020. The Bangladeshi market is also up 1.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Pharmaceuticals industry, which is up 5.0% over the same period.